Edgewise Therapeutics, Inc. ($EWTX)
Filing Information
| Accession Number | 0001644087-26-000005 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 14, 2026 |
| Document | View SEC Filing |
Transactions
11
Total Shares
132,565
Total Value
$412,703.17
P&L
+inf% (+$4,306,575.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CMO | Common Stock | โ | Aug 12, 2026 | Exercise/Conversion | 5,781 | $0.00 | $0.00 | 11,035 | Direct | โ | View Details | |
CMO | Common Stock | โ | Aug 12, 2026 | Exercise/Conversion | 7,031 | $0.00 | $0.00 | 18,066 | Direct | โ | View Details | |
CMO | Common Stock | โ | Aug 12, 2026 | Sale | 2,839 | $43.78 | $124,302.78 | 15,227 | Direct | โ | View Details | |
CMO | Common Stock | โ | Aug 12, 2026 | Sale | 2,779 | $43.71 | $121,462.59 | 12,448 | Direct | โ | View Details | |
CMO | Common Stock | โ | Aug 12, 2026 | Sale | 104 | $44.43 | $4,620.23 | 12,344 | Direct | โ | View Details | |
CMO | Common Stock | โ | Aug 12, 2026 | Sale | 800 | $44.52 | $35,614.00 | 11,544 | Direct | โ | View Details | |
CMO | Common Stock | โ | Aug 13, 2026 | Sale | 2,919 | $43.41 | $126,703.57 | 8,625 | Direct | โ | View Details | |
CMO | Restricted Stock Units | Derivative | Aug 12, 2026 | Exercise/Conversion | 5,781 | $0.00 | $0.00 | 11,563 | Direct | โ | View Details | |
CMO | Restricted Stock Units | Derivative | Aug 12, 2026 | Exercise/Conversion | 7,031 | $0.00 | $0.00 | 21,094 | Direct | โ | View Details | |
CMO | Restricted Stock Units | Derivative | Aug 12, 2026 | Grant/Award | 32,500 | $0.00 | $0.00 | 32,500 | Direct | โ | View Details | |
CMO | Stock Option (Right to Buy) | Derivative | Aug 12, 2026 | Grant/Award | 65,000 | $0.00 | $0.00 | 65,000 | Direct | โ | View Details |